Neuralink ex-president opens rival venture to compete with Elon Musk

Max Hodak He became known for his role as co-founder and former chairman. neuralinkHowever, he left Elon Musk’s company last year. According to new information published on the website Bloomberg🇧🇷 the manager currently runs another US$160 million company in the brain-computer interface (BCI) business.🇧🇷

THEM science company It is Hodak’s new venture that has decided to come back as a competitor to Neuralink as they both work with BCI – it was unclear whether the co-founder left the company voluntarily or was fired. Even in the brain-computer interface industry, $160 million in funding is second only to Musk’s company.

The companies are not as similar as they seem: Unlike Neuralink, Science Corp does not intend to cut off the user’s head to insert a chip. As explained, the company will use photonics technology, in which light is used to send information through the patient’s optic nerve – so users with extreme disabilities could, in theory, benefit from the treatment.

“We are starting in very disabled patient populations with severe unmet needs. But if you develop this technology within five or six generations, it could replace glass. [de realidade virtual] just for the little implant in the eye,” Hodak said in an interview with Bloomberg.

science company

The manager claims the startup has developed a prototype called Science Eye to treat vision loss in rabbits. Basically, a 2 millimeter LED film was placed on the optic nerves of the test rabbits and communication between the brain and the device was established.

Hodak’s goal is to run tests on humans in a few years, but there’s still no estimate – if Neuralink goes his way, the tests will take a long time. In any case, like Musk’s company, Science Corp’s goal is to offer technology that helps treat different special needs.